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Abstract
Small bowel capsule endoscopy is a minimally-invasive 
endoscopic investigation that is often used in clinical 
practice to investigate overt or occult gastrointestinal (GI) 
bleeding among other clinical indications. International 
guidance recommends small bowel capsule endoscopy 
as a first-line investigation to detect abnormalities in 
the small bowel, when gastroscopy and colonoscopy fail 
to identify a cause of GI bleeding. It can diagnose with 
accuracy abnormalities in the small bowel. However, 
there has been increasing evidence indicating that 
small bowel capsule endoscopy may also detect lesions 
outside the small intestine that are within the reach of 
conventional endoscopy and have been probably missed 
during prior endoscopic investigations. Such lesions 
vary from vascular deformities to malignancy and their 
detection often alters patient management, leading to 
further endoscopic and/or surgical interventions. The 
current study attempts to review all available studies in 
the literature and summarise their relevant findings. 
Key words: Obscure gastrointestinal bleeding; Small 
bowel capsule endoscopy; Non-small bowel lesions; 
Overt gastrointestinal bleeding; Occult gastrointestinal 
bleeding; Iron deficiency anaemia 
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Video capsule endoscopy can accurately 
diagnose small bowel pathology, but often also detects 
abnormalities in the upper and lower gastrointestinal 
tract within the reach of conventional endoscopy, that 
have probably been previously overlooked. 
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INTRODUCTION
More than a decade ago, the emergence of novel mo­
dalities for the diagnosis and treatment of small bowel 
diseases revolutionised the landscape of gastrointestinal 
endoscopy. Small bowel capsule endoscopy (SBCE), a 
non­invasive method of direct visualisation of the small 
intestine, was introduced in clinical practice both in 
the United States and Europe in 2001. Since then, the 
use of SBCE has steadily increased with a broadening 
spectrum of clinical indications, and the most common 
application is the investigation of iron deficiency anaemia 
(IDA) and/or obscure gastrointestinal (GI) bleeding[1­3]. 
Traditionally, obscure GI bleeding has been defined as 
overt or occult GI haemorrhage following normal upper 
and lower endoscopic examinations. However, the 
American College of Gastroenterology (ACG) recently 
challenged the current nomenclature, proposing that 
the term “obscure GI bleeding” should be reserved only 
for cases where a source of bleeding was not detected 
following conventional upper and lower GI endosco­
pic examinations and small bowel evaluation[2]. Overt 
GI bleeding refers to patients presenting with either 
melaena or hematochezia, whereas occult GI bleeding 
refers to those presenting with IDA in the absence of 
visible blood loss to the patient or the physician, with or 
without guaiac­positive stools[1].
The ACG recommends that SBCE should be per­
formed as a first-line investigation for the examination 
of the small bowel, following visualisation of the upper 
and lower GI tract, although sometimes a second­
look endoscopy may be indicated[1]. Similarly, the 
British Society of Gastroenterology (BSG) in its recently 
published guidelines on the management of IDA 
recommended that following direct visualisation of the 
upper and lower GI tract, further assessment of the 
small bowel should be performed in the presence of 
symptoms indicating small bowel disease, or in cases 
where the haemoglobin level cannot be restored or 
maintained following iron replacement therapy. In these 
cases, evaluation of the small intestine is indicated, 
and this can be performed by SBCE, which has a 
diagnostic yield of 40%­55% and the advantage of 
being a minimally invasive endoscopic investigation, 
although other options include radiological investigations 
(Magnetic resonance imaging enteroclysis, com­
puted tomography enterography, barium studies) or 
enteroscopy. Findings detected with SBCE are often 
within the reach of conventional endoscopes, hence a 
second­look gastroscopy (OGD) or colonoscopy may 
be of some value[2]. In line with other institutional 
guidelines, the European Society of Gastrointestinal 
Endoscopy (ESGE) also recommends the use of SBCE 
as a first-line modality for the investigation of obscure 
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GI bleeding[3].
ROLE OF SBCE IN THE INVESTIGATION 
OF OBSCURE GI BLEEDING
Up to 30% of patients investigated for IDA may remain 
without a definite diagnosis after evaluation of the 
upper and lower GI tract with conventional endoscopies 
and serological testing for coeliac disease[4]. Similarly, 
in 5% of patients presenting with overt GI bleeding, 
a definite diagnosis is not reached after upper and 
lower GI endoscopy[5]. The advent of SBCE reportedly 
led to the identification of a small-bowel culprit lesion 
in approximately two thirds of cases with ‘obscure’ 
GI bleeding[6­13]. SBCE allows the evaluation of the 
entire small bowel in up to 90% of the patients, with a 
diagnostic yield of 38%­83% in patients with potential 
small bowel haemorrhage[14]. SBCE has a high positive 
(94%­97%) and negative predictive value (83%­100%) 
in the evaluation of GI bleeding[15­16]. Additionally, 
SBCE findings reportedly may lead to a therapeutic 
intervention or overall a change in clinical management 
in 37%­87% of cases[16­17]. The main limitations of 
SBCE include a lack of specificity and a 10%-36% false-
negative rate, as well as failure to identify the major 
duodenal papilla in a significant proportion of patients, 
which potentially could lead to important duodenal 
lesions being missed[18­22]. 
Previous studies or anecdotal reports on SBCE 
referred to patients with non­small bowel lesions mis­
sed during preceding OGD or colonoscopy, indicating 
that these lesions were probably overlooked during 
conventional endoscopy. Non­small bowel lesions 
are defined as lesions proximal to the papilla of Vater 
and distal to the ileocaecal valve. The current study 
attempts to review all available studies in the literature 
and summarize their findings.
LITERATURE STUDY
An extensive bibliographical search was performed 
via the online databases PubMed and EMBASE. The 
keywords used were the following: non­small bowel 
lesions, capsule endoscopy, obscure GI bleeding, small 
bowel bleeding, unexplained IDA. All selected studies 
were manually examined to identify further relevant 
reports. This review included all original research papers 
published in full. Only those written or translated into 
English were included in the full text assessment. A 
subset of ten articles was relevant to this review.
NON-SMALL BOWEL LESIONS 
DETECTED BY SMALL BOWEL CAPSULE 
ENDOSCOPY
Kitiyakara et al[23] reviewed a prospective database of 
140 consecutive patients that were referred to a tertiary 
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University teaching hospital in Sydney, Australia, for 
further management of obscure GI bleeding. The 
referred patients had on average a mean of 2.3 OGDs 
and 2.2 colonoscopies, with no definitive diagnosis. 
Amongst them, 131 had small­bowel follow­through 
and 61 enteroscopy carried out[23]. A definitive or likely 
cause of bleeding was identified in 66% of cases. 
Interestingly, in 6.4% the culprit lesion was within the 
reach of conventional endoscopy[23]. Amongst patients 
with abnormalities in the upper GI tract, 3 women 
had gastric antral vascular ectasia (GAVE) and one 
had an inflammatory­appearing polyp. On the other 
hand, amongst patients with abnormalities identified 
distal to the ileocaecal valve, 2 were diagnosed with 
an adenocarcinoma of the caecum, one had a possible 
caecal tumour and 2 had an angiodysplasia of the 
caecum. In 5 out of 9 patients with non­small bowel 
lesions detected by SBCE, there was active bleeding at 
the time of the examination. Subsequently, all patients 
received appropriate management, based on the 
findings of the SBCE[23].
In 2008, Elijah et al[24] reported that amongst 201 
consecutive SBCE performed in their centre for obscure 
GI bleeding between March 2003 and November 2004, 
78 (38.8%) had a lesion that was within the reach 
of conventional endoscopy. All patients had at least 
one gastroscopy and colonoscopy carried out prior to 
the capsule endoscopy. The majority of patients were 
diagnosed either with erosions or vascular lesions (i.e., 
angiectasias or GAVE). Amongst these patients, 21 had 
an endoscopic intervention carried out and one had 
surgery, as a result of the SBCE findings[24].
Riccioni et al[25] carried out a retrospective study 
to assess whether it is worthwhile performing SBCE in 
patients with unexplained IDA. About 138 patients (in a 
total of 650 consecutive patients) were investigated for 
unexplained IDA. In 2 out of 3 patients (n = 91), SBCE 
identified at least one gastric or small bowel lesion likely 
accounting for IDA. The SBCE findings in decreasing 
order of frequency included angiodysplasias (in 51 
patients), jejunal and/or ileal micro­ulcerations (in 12), 
tumours (in 8), Crohn’s disease, jejunal villous atrophy, 
erosive gastritis, a solitary ileal ulcer, and a small 
bowel polyp (in 1). In 4 patients blood was present in 
the lumen without visible mucosal lesions. Although 
the primary aim of this study was not the evaluation 
of SBCE in the detection of non­small bowel lesions, 
it is noteworthy that 4 patients were found to have 
unexplained IDA secondary to erosive gastritis, that 
surprisingly was not seen during OGD[25]. At the end of 
the follow­up period, an improvement in haemoglobin 
levels after treatment (either medical, endoscopic or 
surgical) was reported, and complete resolution of 
IDA was achieved in 96.25% of patients with positive 
SBCE[25].
Tacheci et al[26] reported the results on 118 con­
secutive SBCE performed in two University hospitals 
for obscure GI bleeding. Overall, gastric lesions were 
detected in 37% of patients and were considered 
significant (potentially haemorrhagic) in 21%. 17% of 
the detected lesions were underestimated or missed at 
conventional endoscopy. The most frequently detected 
lesions were haemorrhagic erosions. 10% of the 
lesions were identified as the source of GI bleeding [26].
Vlachogiannakos et al[27] published a study including 
317 patients (out of 605 in total) who had SBCE 
performed for obscure (occult or overt) GI bleeding. The 
patients had a median of 2 OGDs and 2 colonoscopies 
before the SBCE[27]. Interestingly, small bowel follow­
through had also been performed in 114 patients and 
push enteroscopy in 84. A definite or likely cause of 
GI bleeding was found in 215 patients in the small 
bowel and in 11 cases (3.5%) the source of bleeding 
was outside the small bowel and within the reach of 
conventional endoscopes. Most non­small bowel lesions 
were identified in the caecum (7/11)[27]. Of those 
7 cases, 3 were diagnosed with a carcinoma of the 
caecum. Another patient had a bleeding diverticulum 
in the caecum (preceding colonoscopies had dismissed 
diverticular disease as a cause of overt bleeding due 
to the fact that no signs of bleeding were seen at the 
time of the examination). In addition, 2 patients had 
an angiodysplasia of the caecum and a young patient 
with anaemia, weight loss and bouts of abdominal pain, 
had multiple aphthoid ulcers in the caecum. This patient 
was later diagnosed with Crohn’s disease. In this study, 
there were also 4 patients with non­small bowel lesions 
identified in the upper GI tract: 2 were diagnosed 
with angiodysplasia(s), one patient with longstanding 
anaemia and a medical history of scleroderma was 
diagnosed with GAVE (previously described as antral 
gastritis on repeated OGDs) and the last patient had 
a carcinoma of the cardia[27]. Given the relatively low 
incidence of non­small bowel lesions detected by 
SBCE in this study (3.5%), the authors concluded that 
second­look endoscopy in a tertiary centre prior to 
SBCE would not be a cost­effective strategy and may in 
fact result in a delayed diagnosis[27].
Hoedemaker et al[28] prospectively collected data 
of consecutive SBCE studies performed in a tertiary­
care centre in the Netherlands between 2003 and 
2009. A total of 595 patients were included, the ma­
jority referred for obscure GI bleeding or suspected 
Crohn’s disease. Most patients underwent conventional 
endoscopic examinations prior to referral for SBCE 
(mean number 1.1) and approximately 20% of patients 
had small­bowel­follow­through examination while 
about 10% underwent push enteroscopy[28]. In 14.3% 
of patients, abnormalities were identified within the 
reach of OGD and colonoscopy, and only 2% of those 
lesions had been previously detected. The majority of 
the non­small bowel abnormalities were located in the 
terminal ileum (n = 21) and colon (n = 19), followed 
by abnormalities seen in the stomach (n = 15), the 
duodenum (n = 12), proximal jejunum (n = 10), and in 
other or multiple locations. The most frequent findings 
were angiodysplasias (37.6%), followed by erosions, 
active bleeding without definite mucosal pathology 
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and inflammatory lesions. Regarding patients originally 
referred for suspected Crohn’s disease, abnorma­
lities were seen in the terminal ileum in 33.6%. It is 
interesting that the terminal ileum had been previously 
intubated during colonoscopy in only about 30% of 
cases[28]. The study however, was limited by the fact 
that follow­up data on patients diagnosed with a non­
small bowel lesion at SBCE were lacking. 
Riccioni et al[29] prospectively reviewed data from 
637 patients who underwent SBCE for obscure GI 
bleeding following a “normal” OGD and colonoscopy. 
21.6% of these patients had a definite or likely cause of 
bleeding identified exclusively in the stomach, whereas 
6.5% had a definite or likely cause in the colon; 21% 
had a combination of small bowel and non­small bowel 
lesions[29]. Regarding patients with abnormal findings 
detected in the upper GI tract, 79/138 had multiple 
gastric and duodenal erosions, 11/138 had gastric or 
duodenal ulcers, 13/138 were diagnosed with GAVE, 
11/138 with isolated or multiple angiodysplasias, 
10/138 had multiple erosions in the distal duodenum 
(previously described as “non­specific duodenitis”), 
8/138 were found to have inflammatory­appearing 
polyps and in the remaining patients (out of 138), SBCE 
documented the presence of fundic and esophageal 
varices, antral adenocarcinoma, neoplastic recurrence 
on gastric anastomosis, gastric leiomyoma, and spon­
taneous mucosal bleeding without visible lesions[29]. 
Regarding patients with lesions identified in the lower 
GI tract, 24/41 were found to have isolated or multiple 
angiodysplasias in the caecum and/or ascending colon, 
and 8/41 had erosions or small ulcers at the ileocaecal 
valve or in the caecum. Of the remaining patients (out 
of 41), 3 had a haemorrhagic­appearing caecal mucosa 
without obvious lesions (all 3 were diagnosed with 
adenocarcinoma of the colon on repeat colonoscopy and 
were treated accordingly), 3 had non-specific “irregularity” 
of the mucosa of the right colon, 2 had a large bleeding 
caecal polyp and one patient had diverticular disease 
of the right colon with active bleeding[29]. About 75.3% 
of patients with gastric lesions and 65.8% with colonic 
lesions did not have further presentations with obscure 
GI bleeding following diagnosis reached by SBCE and 
effective endoscopic and/or surgical management[29].
Akin et al[30] recently reviewed prospectively collected 
databases of patients referred to a tertiary teaching 
hospital in Turkey for potential small bowel bleeding, 
after inconclusive upper and lower conventional endo­
scopy. These patients were referred for SBCE and 114 
met the inclusion criteria of the study[30]. In 50% of 
cases a definite or likely cause of the bleeding was 
identified and amongst them, 8 patients (approximately 
7%) were reported to have non­small bowel lesions 
within the reach of conventional endoscopy[30]. The 
majority of these findings were identified in the caecum 
(5/8). Overall, 5 out of 8 patients had angiodysplasia(s) 
and 4 of them had active bleeding at the time of 
examination. In a patient with occult GI bleeding GAVE 
was found. Previous endoscopic examination of the 
upper GI tract misdiagnosed the above finding as 
antral gastritis. In a patient with past medical history 
of Billroth Ⅱ gastrectomy, active bleeding from an 
anastomotic ulcer was detected. Another patient had 
active bleeding distal to the duodenal bulb at the 
time of the SBCE examination, without a definitive 
lesion seen. A subsequent second­look endoscopy 
confirmed the presence of an angiodysplasia. Finally, 
a patient investigated for anaemia and abdominal pain 
was found to have a caecal ulcer on a caecal fold. A 
repeat colonoscopy with biopsies was performed and 
histologically “chronic active colitis” was shown[30].
Juanmartiñena Fernández et al[31] retrospectively 
analyzed data from 2217 consecutive SBCE performed 
in a tertiary centre in Spain between 2008 and 
2016. 52.3% of the patients were referred for occult 
GI bleeding. The rest were referred for Crohn’s dis­
ease, abdominal pain, chronic diarrhoea or other 
indications[31]. SBCE detected gastroduodenal lesions 
in 566 patients. More than 80% had previously had 
1.29 ± 1.1 (1­10) gastroscopies carried out, the vast 
majority within 30 mo prior to the SBCE. Among 
patients with gastric or duodenal lesions detected at 
SBCE, 75.4% and 86.4% respectively did not have 
these abnormalities found at prior endoscopies. Lesions 
identified more frequently in the stomach included 
erosions, vascular lesions and findings suggestive of 
chronic gastritis, while lesions found more frequently in 
the duodenum included erosions, erythema or vascular 
lesions[31]. Lesions revealed by SBCE led to a change to 
the initial therapeutic strategy in 60.6% of the patients. 
In 12.8% an endoscopic intervention was carried out 
(most frequently argon plasma coagulation for vascular 
changes) and in 1.2% a surgical intervention was 
performed[31]. Juanmartiñena Fernández et al[32] also 
analyzed 526 consecutive SBCE performed in their 
centre between 2008 and 2011, in order to assess 
detection of colonic lesions identified at SBCE[32]. 
Interestingly, 85.7% had a prior colonoscopy done 
within two years from the SBCE. Colonic abnormalities 
were detected in 47 patients (9%) and in 33 out of 
47 cases synchronous small bowel lesion(s) were 
detected. In 66.6% out of them, capsule endoscopy 
identified findings, which had been overlooked during 
prior endoscopy. The most frequent findings were 
vascular lesions (41.8%) and colonic ulcers (20.8%). 
Treatment changes after SBCE led to an overall change 
to the initial therapeutic strategy in almost 60% of the 
patients[32]. Findings are summarized in Table 1.
DISCUSSION
Obscure GI bleeding, either overt or occult, is a common 
presentation, encountered in 5%­10% of cases of GI 
bleeding[30]. Conventional upper and lower GI endoscopy 
often fails to identify the source of bleeding and cannot 
visualise the entire GI tract. Similarly, radiology may 
detect small bowel masses and/or large ulcerating 
lesions but lacks sensitivity in detecting subtle mucosal 
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abnormalities[33]. Push enteroscopy identifies a potential 
source of bleeding in up to 40% of patients presenting 
with obscure GI bleeding. The main limitations of push 
enteroscopy are operator­dependency, the fact that it 
does not allow visualisation of the entire small bowel, 
and that it is an invasive procedure[25].
The introduction of SBCE in clinical practice, a 
minimally­invasive modality of visualising the entire 
small bowel, led to the detection of a small­bowel source 
of obscure GI bleeding in approximately two thirds of 
cases [6­13]. Another novel modality of visualising directly 
the small bowel is device­assisted enteroscopy (DAE). 
DAE includes double­balloon enteroscopy, single­balloon 
enteroscopy, spiral enteroscopy and balloon­guided 
endoscopy. DAE shares almost the same limitations 
as push enteroscopy, but has the advantage of real­
time inspection of the lumen and the option of tissue 
sampling and endoscopic treatment if required[3,24]. 
SBCE allows the evaluation of the entire small bowel 
in up to 90% of cases, has a diagnostic yield of up to 
83% in patients with potential small bowel bleeding and 
its findings may lead to a change in management in 
37%–87% of cases[14­17]. Several comparative studies 
demonstrated SBCE superiority over barium follow­
through (31% vs 5%)[7], push enteroscopy (50% vs 
24%)[34], CT enteroclysis (59% vs 36%)[35], intraoperative 
enteroscopy (74.4% vs 68%)[36], and angiography 
(72% vs 56%)[37]. In comparison to double­balloon 
enteroscopy, it has a similar diagnostic yield in detecting 
small­bowel lesions (55.3% vs 60.5%)[38]. Thus, many 
gastrointestinal societies, such as ACG, BSG and ESGE 
recommend the use of SBCE as first-line investigation 
for obscure GI bleeding following normal OGD and 
colonoscopy[1­3].
Until recently, the focus of most studies has been the 
actual findings within the small bowel. However, there 
has been increasing evidence suggesting that non­small 
bowel lesions detected by SBCE are sometimes within 
the reach of conventional endoscopy and have probably 
been missed at previous upper and lower GI endoscopy. 
In 2004, Tang et al[39] reported that among 46 patients 
that underwent SBCE for obscure GI bleeding, 5 had 
a lesion likely overlooked during prior endoscopies[39]. 
To the best of our knowledge, since then, there have 
only been very few studies published to date relevant 
to non­small bowel lesions overlooked by OGD and 
colonoscopy. 
The reason why such lesions are often missed cannot 
be determined with confidence. A possible explanation 
for overlooking a non­small bowel lesion may be the 
small size or unusual site, posing a challenge in its de­
tection. Additionally, air insufflated during conventional 
endoscopy may lead to suboptimal appearance of the 
lesion, as a consequence of vasculature compression, 
especially for vascular or subtle mucosal abnormalities. 
It is also interesting that in most studies included in this 
review, GAVE was misinterpreted as antral gastritis in 
a significant proportion of patients. In 2006, Sidhu et 
al[40] reported 6 cases of GAVE detected during SBCE 
that were previously missed at conventional endoscopy, 
most frequently misdiagnosed as antral gastritis. In 
addition, luminal endoscopy performed in anaemic 
patients or in patients with low blood pressure may 
result in the findings being less prominent, especia­
lly if sedation is also administered. A non­bleeding 
lesion may also be harder to detect. As suggested 
by Kitiyakara et al[23], SBCE may induce bleeding by 
traumatizing the mucosa which subsequently “reveals” 
Table 1  Summary of publications studying non-small bowel lesions detected at capsule endoscopy
References Presentation (GI 
bleeding)
Mean duration 
(mo)1
No of SBCE 
(n)
NSBL detection 
(n)
Most frequent site of 
NSBL
Most frequent 
lesion(s)
Kitiyakara et al[23] Obscure 23.1 140 9 Colon GAVE
Elijah et al[24] Obscure Not 201 78 Only upper GI reported Vascular lesions
specified
Riccioni et al[25]2 Occult Not 138 Not Not Angiody-splasia
specified specified specified
Tacheci et al[26] Obscure Not 118 20 Only upper GI reported Erosions
specified
Vlachogiannakos et al[27] Obscure 8.6 317 11 Colon Angiodysplasia and 
cancer
Hoedemaker et al[28] Obscure Not 595 85 Terminal Ileum Angiody-splasia
specified
Riccioni et al[29] Not 637 179 Stomach/ duodenum Gastric - duodenal 
erosionsObscure specified
Akin et al[30] Obscure Not 114 8 Caecum Angiody-splasia
specified
Juanmartiñena Fernández et al[31] Obscure or other 
indications 
19.8 2217 447 Only upper GI reported Erosions
Juanmartiñena Fernández et al[32] Obscure or other 
indications
25 526 24 Only lower GI reported Vascular lesions
1Mean duration of presenting symptom; 2Riccioni et al[25] studied the role of small capsule endoscopy in investigating unexplained iron deficiency anaemia. 
SBCE: Small capsule endoscopy; NSBL: Non-small bowel lesion (defined as lesions within the reach of conventional upper and lower gastrointestinal 
endoscopy. This may include the terminal ileum; IDA: Iron deficiency anaemia; GI: Gastrointestinal.
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the lesion. With regard to colonoscopy, failure to reach 
the caecum either due to actual inability to reach it, or 
due to misidentification of the caecum by the endoscopist 
and premature termination of the endoscopy, may lead 
to missed pathology. Intubation of the ileocaecal valve 
and inspection of the terminal ileum also appears to be 
invaluable. Lesions behind colonic haustral folds and 
poor bowel preparation especially in the right colon are 
other possible explanations for missed lesions.
The prevalence of non­small bowel lesions missed 
at conventional endoscopy or push enteroscopy varied 
significantly between studies, from 3.5% to more 
than 30%[23­32]. Vlachogiannakos et al[27] report a 
statistically significant difference in the rates of such 
lesions being missed at endoscopy between different 
healthcare centres. In most studies, the relevant lesion 
was detected in the lower GI tract more frequently 
than in the upper GI tract. Regarding patients with 
overlooked lesions located in the upper GI tract, antrum 
is a frequent site where such lesions are found[23­32]. 
Interestingly, colonic diagnoses were made using a 
SBCE, which is not designed to explore and examine 
the colon. Vascular lesions (either angiodysplasia or 
GAVE) were the most frequently detected abnormality. 
Other common findings included ulcers or erosions, 
tumours, polyps, inflammation, or GI bleeding due to 
diverticular disease. Although not assessed in all of 
the included studies, in the majority of patients the 
diagnosis was followed by interventional endoscopic 
or surgical treatment and/or conservative medical 
therapy. Treatment changes after SBCE most frequently 
included iron supplements, argon plasma coagulation 
for vascular lesions (angiodysplasia) and surgery for 
patients diagnosed with cancer. Lesions revealed by 
SBCE led to a change to the initial therapeutic strategy 
in up to 60% of patients[31,32]. In one of the studies, an 
improvement in haemoglobin levels after treatment and 
complete resolution of IDA was achieved in more than 
95% of patients with positive findings at SBCE[25].
In conclusion, SBCE is a minimally­invasive endo­
scopic investigation that can accurately diagnose small 
bowel pathology, but often also detects abnormalities 
in the upper and lower GI tract that are within the 
reach of conventional endoscopy. The prevalence of 
such lesions that have been overlooked at conventional 
endoscopy is somewhat alarming, especially when 
considering the wide range of missed pathology that 
may include benign lesions, such as gastric or duodenal 
erosions, or significant abnormalities, such as malignant 
tumours. Great care should be taken in performing 
endoscopy carefully and under optimal conditions to 
maximize diagnostic accuracy and avoid unnecessary 
repeat examinations, leading to an increased cost and 
potentially hazardous delays in reaching a diagnosis. 
SBCE is a safe and reliable means of investigating 
further the GI tract, provided the procedure is carried 
out correctly and adequately trained healthcare 
professionals are interpreting the results. Our study 
is limited by the fact that most cases presented in the 
literature, which are summarised in the current review, 
are retrospectively assessing patient data; therefore 
prospective studies are mandated to validate the 
findings.
REFERENCES
1  Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG Clinical 
Guideline: Diagnosis and Management of Small Bowel Bleeding. 
Am J Gastroenterol 2015; 110: 1265-87; quiz 1288 [PMID: 
26303132 DOI: 10.1038/ajg.2015.246]
2  Goddard AF, James MW, McIntyre AS, Scott BB; British Society 
of Gastroenterology. Guidelines for the management of iron 
deficiency anaemia. Gut 2011; 60: 1309-1316 [PMID: 21561874 
DOI: 10.1136/gut.2010.228874]
3  Pennazio M, Spada C, Eliakim R, Keuchel M, May A, Mulder CJ, 
Rondonotti E, Adler SN, Albert J, Baltes P, Barbaro F, Cellier C, 
Charton JP, Delvaux M, Despott EJ, Domagk D, Klein A, McAlindon 
M, Rosa B, Rowse G, Sanders DS, Saurin JC, Sidhu R, Dumonceau 
JM, Hassan C, Gralnek IM. Small-bowel capsule endoscopy and 
device-assisted enteroscopy for diagnosis and treatment of small-
bowel disorders: European Society of Gastrointestinal Endoscopy 
(ESGE) Clinical Guideline. Endoscopy 2015; 47: 352-376 [PMID: 
25826168 DOI: 10.1055/s-0034-1391855]
4  Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in 
patients with iron-deficiency anemia. N Engl J Med 1993; 329: 
1691-1695 [PMID: 8179652 DOI: 10.1056/NEJM199312023292303]
5  Westerhof J, Koornstra JJ, Weersma RK. Capsule endoscopy: a 
review from the clinician’s perspectives. Minerva Gastroenterol 
Dietol 2008; 54: 189-207 [PMID: 18319691]
6  Scapa E, Jacob H, Lewkowicz S, Migdal M, Gat D, Gluckhovski 
A, Gutmann N, Fireman Z. Initial experience of wireless-capsule 
endoscopy for evaluating occult gastrointestinal bleeding and suspected 
small bowel pathology. Am J Gastroenterol 2002; 97: 2776-2779 
[PMID: 12425547 DOI: 10.1111/j.1572-0241.2002.07021.x]
7  Costamagna G, Shah SK, Riccioni ME, Foschia F, Mutignani M, 
Perri V, Vecchioli A, Brizi MG, Picciocchi A, Marano P. A prospective 
trial comparing small bowel radiographs and video capsule endoscopy 
for suspected small bowel disease. Gastroenterology 2002; 123: 
999-1005 [PMID: 12360460 DOI: 10.1053/gast.2002.35988]
8  Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients 
with suspected small intestinal bleeding: Results of a pilot study. 
Gastrointest Endosc 2002; 56: 349-353 [PMID: 12196771 DOI: 
10.1016/S0016-5107(02)70037-0]
9  Ell C, Remke S, May A, Helou L, Henrich R, Mayer G. The first 
prospective controlled trial comparing wireless capsule endoscopy 
with push enteroscopy in chronic gastrointestinal bleeding. 
Endoscopy 2002; 34: 685-689 [PMID: 12195324 DOI: 10.1055/
s-2002-33446]
10  Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule 
endoscopy: a comparison with push enteroscopy in patients with 
gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut 
2003; 52: 1122-1126 [PMID: 12865269 DOI: 10.1136/gut.52.8.1122]
11  Chong AK, Taylor AC, Miller AM, Desmond PV. Initial experience 
with capsule endoscopy at a major referral hospital. Med J Aust 
2003; 178: 537-540 [PMID: 12765499]
12  Selby W. Can clinical features predict the likelihood of finding 
abnormalities when using capsule endoscopy in patients with GI 
bleeding of obscure origin? Gastrointest Endosc 2004; 59: 782-787 
[PMID: 15173789 DOI: 10.1016/S0016-5107(04)00168-3]
13  Adler DG, Knipschield M, Gostout C. A prospective comparison 
of capsule endoscopy and push enteroscopy in patients with GI 
bleeding of obscure origin. Gastrointest Endosc 2004; 59: 492-498 
[PMID: 15044884 DOI: 10.1016/S0016-5107(03)02862-1]
14  Rondonotti E, Villa F, Mulder CJ, Jacobs MA, de Franchis R. Small 
bowel capsule endoscopy in 2007: indications, risks and limitations. 
World J Gastroenterol 2007; 13: 6140-6149 [PMID: 18069752 DOI: 
10.3748/wjg.v13.i46.6140]
15  Delvaux M, Fassler I, Gay G. Clinical usefulness of the endoscopic 
Koffas A et al . Non-small bowel lesion detection at small bowel capsule endoscopy
907 December 6, 2018|Volume 6|Issue 15|WJCC|www.wjgnet.com
video capsule as the initial intestinal investigation in patients with 
obscure digestive bleeding: validation of a diagnostic strategy 
based on the patient outcome after 12 months. Endoscopy 2004; 36: 
1067-1073 [PMID: 15578296 DOI: 10.1055/s-2004-826034]
16  Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, 
Rossini FP, De Franchis R. Outcome of patients with obscure 
gastrointestinal bleeding after capsule endoscopy: report of 100 
consecutive cases. Gastroenterology 2004; 126: 643-653 [PMID: 
14988816 DOI: 10.1053/j.gastro.2003.11.057]
17  Ben Soussan E, Antonietti M, Hervé S, Savoye G, Ramirez S, 
Lecleire S, Ducrotté P, Lerebours E. Diagnostic yield and therapeutic 
implications of capsule endoscopy in obscure gastrointestinal 
bleeding. Gastroenterol Clin Biol 2004; 28: 1068-1073 [PMID: 
15657528 DOI: 10.1016/S0399-8320(04)95183-4]
18  Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort 
JG; Investigators. Video capsule endoscopy to prospectively assess 
small bowel injury with celecoxib, naproxen plus omeprazole, and 
placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141 [PMID: 
15704047 DOI: 10.1016/S1542-3565(04)00619-6]
19  Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate 
results of capsule endoscopy trials. Endoscopy 2005; 37: 960-965 
[PMID: 16189768 DOI: 10.1055/s-2005-870353]
20  Appleyard M, Fireman Z, Glukhovsky A, Jacob H, Shreiver R, 
Kadirkamanathan S, Lavy A, Lewkowicz S, Scapa E, Shofti R, 
Swain P, Zaretsky A. A randomized trial comparing wireless capsule 
endoscopy with push enteroscopy for the detection of small-bowel 
lesions. Gastroenterology 2000; 119: 1431-1438 [PMID: 11113063 
DOI: 10.1053/gast.2000.20844]
21  Kong H, Kim YS, Hyun JJ, Cho YJ, Keum B, Jeen YT, Lee HS, 
Chun HJ, Um SH, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. 
Limited ability of capsule endoscopy to detect normally positioned 
duodenal papilla. Gastrointest Endosc 2006; 64: 538-541 [PMID: 
16996345 DOI: 10.1016/j.gie.2006.02.028]
22  Clarke JO, Giday SA, Magno P, Shin EJ, Buscaglia JM, Jagannath 
SB, Mullin GE. How good is capsule endoscopy for detection 
of periampullary lesions? Results of a tertiary-referral center. 
Gastrointest Endosc 2008; 68: 267-272 [PMID: 18378233 DOI: 
10.1016/j.gie.2007.11.055]
23  Kitiyakara T, Selby W. Non-small-bowel lesions detected by 
capsule endoscopy in patients with obscure GI bleeding. Gastrointest 
Endosc 2005; 62: 234-238 [PMID: 16046986 DOI: 10.1016/
S0016-5107(05)00292-0]
24  Elijah D, Daas A, Brady P. Capsule endoscopy for obscure GI 
bleeding yields a high incidence of significant treatable lesions within 
reach of standard upper endoscopy. J Clin Gastroenterol 2008; 42: 
962-963 [PMID: 18645532 DOI: 10.1097/MCG.0b013e31811edce5]
25  Riccioni ME, Urgesi R, Spada C, Cianci R, Pelecca G, Bizzotto 
A, Costamagna G. Unexplained iron deficiency anaemia: Is it 
worthwhile to perform capsule endoscopy? Dig Liver Dis 2010; 42: 
560-566 [PMID: 20227929 DOI: 10.1016/j.dld.2010.01.023]
26  Tacheci I, Devière J, Kopacova M, Douda T, Bures J, Van Gossum 
A. The importance of upper gastrointestinal lesions detected with 
capsule endoscopy in patients with obscure digestive bleeding. Acta 
Gastroenterol Belg 2011; 74: 395-399 [PMID: 22103043]
27  Vlachogiannakos J, Papaxoinis K, Viazis N, Kegioglou A, Binas 
I, Karamanolis D, Ladas SD. Bleeding lesions within reach of 
conventional endoscopy in capsule endoscopy examinations 
for obscure gastrointestinal bleeding: is repeating endoscopy 
economically feasible? Dig Dis Sci 2011; 56: 1763-1768 [PMID: 
21302137 DOI: 10.1007/s10620-011-1592-3]
28  Hoedemaker RA, Westerhof J, Weersma RK, Koornstra JJ. Non-
small-bowel abnormalities identified during small bowel capsule 
endoscopy. World J Gastroenterol 2014; 20: 4025-4029 [PMID: 
24744592 DOI: 10.3748/wjg.v20.i14.4025]
29  Riccioni ME, Urgesi R, Cianci R, Marmo C, Galasso D, 
Costamagna G. Obscure recurrent gastrointestinal bleeding: a 
revealed mystery? Scand J Gastroenterol 2014; 49: 1020-1026 
[PMID: 24945819 DOI: 10.3109/00365521.2014.898327]
30  Akin FE, Yurekli OT, Demirezer Bolat A, Tahtacı M, Koseoglu H, 
Selvi E, Buyukasik NS, Ersoy O. Analysis of Non-Small Bowel 
Lesions Detected by Capsule Endoscopy in Patients with Potential 
Small Bowel Bleeding. Diagn Ther Endosc 2016; 2016: 9063293 
[PMID: 27092029 DOI: 10.1155/2016/9063293]
31  Juanmartiñena Fernández JF, Fernández-Urien Sainz I, Zabalza 
Ollo B, Saldaña Dueñas C, Montañés Guimera M, Elosua González 
A, Vila Costas JJ. Gastroduodenal lesions detected during small 
bowel capsule endoscopy: incidence, diagnostic and therapeutic 
impact. Rev Esp Enferm Dig 2018; 110: 102-108 [PMID: 29152990]
32  Juanmartiñena Fernández JF, Fernández-Urién Sainz I, Zabalza 
Ollo B, Borda Martín A, Vila Costas JJ. Colonic lesions in patients 
undergoing small bowel capsule endoscopy: incidence, diagnostic 
and therapeutic impact. Rev Esp Enferm Dig 2017; 109: 498-502 
[PMID: 28593783 DOI: 10.17235/reed.2017.4604/2016]
33  Milano A, Balatsinou C, Filippone A, Caldarella MP, Laterza F, 
Lapenna D, Pierdomenico SD, Pace F, Cuccurullo F, Neri M. A 
prospective evaluation of iron deficiency anemia in the GI endoscopy 
setting: role of standard endoscopy, videocapsule endoscopy, and 
CT-enteroclysis. Gastrointest Endosc 2011; 73: 1002-1008 [PMID: 
21396638 DOI: 10.1016/j.gie.2011.01.006]
34  de Leusse A, Vahedi K, Edery J, Tiah D, Fery-Lemonnier E, Cellier 
C, Bouhnik Y, Jian R. Capsule endoscopy or push enteroscopy 
for first-line exploration of obscure gastrointestinal bleeding? 
Gastroenterology 2007; 132: 855-62; quiz 1164-5 [PMID: 17324401 
DOI: 10.1053/j.gastro.2006.12.002]
35  Voderholzer WA, Ortner M, Rogalla P, Beinhölzl J, Lochs H. 
Diagnostic yield of wireless capsule enteroscopy in comparison with 
computed tomography enteroclysis. Endoscopy 2003; 35: 1009-1014 
[PMID: 14648412 DOI: 10.1055/s-2003-44583]
36  Hartmann D, Schmidt H, Schilling D, Kinze F, Eickhoff A, 
Weickert U, Schulz HJ, Riemann JF. Follow-up of patients with 
obscure gastrointestinal bleeding after capsule endoscopy and 
intraoperative enteroscopy. Hepatogastroenterology 2007; 54: 
780-783 [PMID: 17591061]
37  Saperas E, Dot J, Videla S, Alvarez-Castells A, Perez-Lafuente M, 
Armengol JR, Malagelada JR. Capsule endoscopy versus computed 
tomographic or standard angiography for the diagnosis of obscure 
gastrointestinal bleeding. Am J Gastroenterol 2007; 102: 731-737 
[PMID: 17397406 DOI: 10.1111/j.1572-0241.2007.01058.x]
38  Fukumoto A, Tanaka S, Shishido T, Takemura Y, Oka S, Chayama K. 
Comparison of detectability of small-bowel lesions between capsule 
endoscopy and double-balloon endoscopy for patients with suspected 
small-bowel disease. Gastrointest Endosc 2009; 69: 857-865 [PMID: 
19136103 DOI: 10.1016/j.gie.2008.06.007]
39  Tang SJ, Christodoulou D, Zanati S, Dubcenco E, Petroniene R, 
Cirocco M, Kandel G, Haber GB, Kortan P, Marcon NE. Wireless 
capsule endoscopy for obscure gastrointestinal bleeding: a single-
centre, one-year experience. Can J Gastroenterol 2004; 18: 559-565 
[PMID: 15457295 DOI: 10.1155/2004/205685]
40  Sidhu R, Sanders DS, McAlindon ME. Does capsule endoscopy 
recognise gastric antral vascular ectasia more frequently than 
conventional endoscopy? J Gastrointestin Liver Dis 2006; 15: 
375-377 [PMID: 17205150]
P- Reviewer: Christodoulou DK, Goncalves TC, Trifan A, Neri M 
S- Editor: Wang JL    L- Editor: A    E- Editor: Wu YXJ
Koffas A et al . Non-small bowel lesion detection at small bowel capsule endoscopy
                                      © 2018 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.f6publishing.com/helpdesk
http://www.wjgnet.com
